Business Description
Mainz Biomed NV
ISIN : NL0015000LC2
Description
Financial Strength
1/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 0.12 | |||||
Equity-to-Asset | -0.49 | |||||
Debt-to-Equity | -2 | |||||
Debt-to-EBITDA | -0.33 | |||||
Interest Coverage | N/A | |||||
Piotroski F-Score | N/A/9 | |||||
Altman Z-Score | -21.7 | |||||
Beneish M-Score | -5.84 | |||||
WACC vs ROIC |
Growth Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 9.4 | |||||
3-Year EBITDA Growth Rate | -310 | |||||
3-Year EPS without NRI Growth Rate | -212.9 | |||||
3-Year FCF Growth Rate | -229.6 | |||||
Future 3-5Y EPS without NRI Growth Rate Estimate | 25.27 | |||||
Future 3-5Y Total Revenue Growth Rate Estimate | 114.71 |
Momentum Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 29.37 | |||||
9-Day RSI | 41.23 | |||||
14-Day RSI | 44.73 | |||||
6-1 Month Momentum % | -76.56 | |||||
12-1 Month Momentum % | -90.91 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 0.24 | |||||
Quick Ratio | 0.19 | |||||
Cash Ratio | 0.1 | |||||
Days Inventory | 476.58 | |||||
Days Sales Outstanding | 44.5 | |||||
Days Payable | 1952.66 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -21.8 | |||||
Shareholder Yield % | -148.65 |
Profitability Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 56.92 | |||||
Operating Margin % | -2997.21 | |||||
Net Margin % | -2934.82 | |||||
FCF Margin % | -2664.74 | |||||
ROE % | -1359.67 | |||||
ROA % | -172.22 | |||||
ROIC % | -201.97 | |||||
3-Year ROIIC % | -230.04 | |||||
ROC (Joel Greenblatt) % | -800.75 | |||||
ROCE % | -517.65 |
GF Value Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PS Ratio | 4.63 | |||||
EV-to-EBIT | -0.54 | |||||
EV-to-EBITDA | -0.56 | |||||
EV-to-Revenue | 15.53 | |||||
EV-to-Forward-Revenue | 5.94 | |||||
EV-to-FCF | -0.58 | |||||
Earnings Yield (Greenblatt) % | -185.19 | |||||
FCF Yield % | -359.71 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
Mainz Biomed NV Executives
DetailsGF Value
Analyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil €) | 0.831 | ||
EPS (TTM) (€) | -1.522 | ||
Beta | 0 | ||
Volatility % | 83.02 | ||
14-Day RSI | 44.73 | ||
14-Day ATR (€) | 0.031263 | ||
20-Day SMA (€) | 0.25785 | ||
12-1 Month Momentum % | -90.91 | ||
52-Week Range (€) | 0.173 - 3.18 | ||
Shares Outstanding (Mil) | 25.59 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 9999 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Mainz Biomed NV Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Mainz Biomed NV Stock Events
Event | Date | Price(€) | ||
---|---|---|---|---|
No Event Data |
Mainz Biomed NV Frequently Asked Questions
What is Mainz Biomed NV(STU:4TO)'s stock price today?
When is next earnings date of Mainz Biomed NV(STU:4TO)?
Does Mainz Biomed NV(STU:4TO) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |